18 and older, any sex, with Chronic Pain or Alcohol Use, Unspecified. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Brief Pain Inventory Pain SeverityPrimary· past 7 days
BPI consists of 11-point scale items that reflect pain severity and pain interference Average pain severity in the past 7-days is measures with a single 11-point scale where "0" is best and "10" is worst.
Pain interference is measures as the mean of 7-items, each also rated on a 11-point scale where "0" is best and "10 is worst" Scales range from 0 - 10
Group
Value
95% CI
Intervention
5.0
± 2.58
Brief Pain Inventory Pain InterferencePrimary· past 7 days
BPI consists of 11-point scale items that reflect pain severity and pain interference
Pain interference is measured as the mean of 7-items, each rated on a 11-point scale where "0" is best and "10 is worst" Scales range from 0 - 10
Group
Value
95% CI
Intervention
2.43
± 2.68
Alcohol Time Line Follow Back...Heavy Drinking EpisodesPrimary· past 30 days
number of heavy drinking episodes in the past 30 days
Group
Value
95% CI
Intervention
2.0
± 4.34
Alcohol Time Line Follow Back...Average Drinks Per WeekPrimary· past 30 days
average number of drinks per week in the past 30 days (total number of drinks 30 days/4.28)
Group
Value
95% CI
Intervention
13
± 21.57
Client Satisfaction Questionnaire-8 [Modified]Primary· past 30 days
Evaluative ratings of the intervention received. Eight Likert-scale items regarding different components of treatment satisfaction are rated from 1-4. Some items are reversed scored and then they are summed so that higher scores reflect higher satisfaction with treatment.
The possible range of scores is 8-32.
Group
Value
95% CI
Intervention
29.29
± 2.29
Perceptions of Treatment QuestionnairePrimary· past 30 days
Participants were asked about their experiences with different facets of the intervention using items that were scored from 0 - 8 with higher scores reflecting greater satisfaction with the treatment components.
Group
Value
95% CI
Intervention
7.04
± 1.15
Goal Systems Assessment Battery-PainSecondary· past 30 days
Ratings self-regulatory capacities related to pain. Participants rate their perceived self-regulatory skills related to pain management using 5-point Likert scale items. There are 4 subscales for each of the dimensions of self-regulation assessed; planning, monitoring, self-efficacy, and value about the behavior change goal. A mean scale score is taken for each subscale. The range for each subscale is 0-4. Higher scores reflect better outcomes.
Pain-Value
Group
Value
95% CI
Intervention
3.25
± 0.70
Pain-Self-efficacy
Group
Value
95% CI
Intervention
3.0
± 0.84
Pain-Monitoring
Group
Value
95% CI
Intervention
3.0
± 0.92
Pain-Planning
Group
Value
95% CI
Intervention
2.75
± 0.89
Goal Systems Assessment Battery-AlcoholSecondary· past 30 days
Ratings self-regulatory capacities related to moderating alcohol use. Participants rate their perceived self-regulatory skills related to pain management using 5-point Likert scale items. There are 4 subscales for each of the dimensions of self-regulation assessed; planning, monitoring, self-efficacy, and value about the behavior change goal. A mean scale score is taken for each subscale. The range for each subscale is 0-4. Higher scores reflect better outcomes.
Alcohol-Value
Group
Value
95% CI
Intervention
3.0
± 0.87
Alcohol-Self-efficacy
Group
Value
95% CI
Intervention
3.0
± 0.71
Alcohol-Monitoring
Group
Value
95% CI
Intervention
2.75
± 0.82
Alcohol-Planning
Group
Value
95% CI
Intervention
2.75
± 0.89
Sponsor's own description
This research seeks to develop a novel, integrated behavioral approach to reduce heavy drinking and chronic pain among patients in HIV-care delivered via internet-based videoconferencing. This first open trial pilot study seeks to recruit patients in the clinic through posted flyers, cards and physician referral.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity
· NA
· recruiting
NCT07425691 — SPACE for Youth With Chronic Pain
· recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling
· Phase 1
· recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD
· NA
· recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain
· NA
· recruiting
Other Boston University Charles River Campus trials
Trials by the same sponsor.
NCT07461584 — Memory Enhancement in Aging With Optimal Dosing
· EARLY_PHASE1
· not yet recruiting
NCT07208318 — Restructuring the Alpha-Gamma Code in Aging Vision
· EARLY_PHASE1
· not yet recruiting
NCT06182241 — Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boston University Charles River Campus
Last refreshed: 13 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03982433.